IL1B and pneumococcal infection: Similarly, in a lethal post-influenza pneumococcal infection mouse model, TSA (1 mg/kg administered 1 h after pneumococcal infection and continued daily throughout the course of the experiment) significantly decreased IL-1β in serum 36 h after pneumococcal infection [36].